Back
Keros Therapeutics Stock Price Chart
Sell
20
KROS
Keros Therapeutics
Last Price:
54.03
Seasonality Move:
-7.87%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
Keros Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.3 | Sell |
| 20-day SMA: | 56.87 | Sell |
| 50-day SMA: | 61.47 | Sell |
| 200-day SMA: | 45.32 | Buy |
| 8-day EMA: | 55.49 | Sell |
| 20-day EMA: | 57.17 | Sell |
| 50-day EMA: | 58.61 | Sell |
| 200-day EMA: | 50.7 | Buy |
Keros Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.65 | Sell |
| Relative Strength Index (14 RSI): | 40.71 | Sell |
| Chaikin Money Flow: | 82506 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.1 - 59.56) | Sell |
| Bollinger Bands (100): | (50.3 - 65.58) | Sell |
Keros Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 54.40 while KROS 8-day simple moving average is 56.30, which is a Sell signal.
- The stock price of KROS is 54.40 while Keros Therapeutics 20-day SMA is 56.87, which makes it a Sell.
- Keros Therapeutics 50-day simple moving average is 61.47 while KROS share price is 54.40, making it a Sell technically.
- KROS stock price is 54.40 and Keros Therapeutics 200-day simple moving average is 45.32, creating a Buy signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
20
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a Sell
The current Keros Therapeutics [KROS] share price is $54.40. The Score for KROS is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
1.96B
Price in USD:
54.40
Share Volume:
198.98K
Keros Therapeutics 52-Week Range
52-Week High:
73.00
52-Week Low:
27.02
Sell
20
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?
The Keros Therapeutics stock price is 54.40 USD today. -
Will KROS stock go up or go down?
Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Keros Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
- Keros Therapeutics share price is 54.40 while KROS 8-day exponential moving average is 55.49, which is a Sell signal.
- The stock price of KROS is 54.40 while Keros Therapeutics 20-day EMA is 57.17, which makes it a Sell.
- Keros Therapeutics 50-day exponential moving average is 58.61 while KROS share price is 54.40, making it a Sell technically.
- KROS stock price is 54.40 and Keros Therapeutics 200-day simple moving average is 50.70, creating a Buy signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.04 per share, an increase this year of $0.25 per share, and a decrease next year of $0.39 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
- KROS Moving Average Covergence Divergence (MACD) indicator is -1.65, suggesting Keros Therapeutics is a Sell
- Keros Therapeutics Relative Strength Index (RSI) is 40.71, which suggest Keros Therapeutics is oversold
- The Bollinger Bands (25) for Keros Therapeutics is (55.1 - 59.56), which suggest Keros Therapeutics is a Sell
- The Bollinger Bands (100) for Keros Therapeutics is (50.3 - 65.58), which suggest Keros Therapeutics is a Sell
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.